Abstract
To correlate polymorphisms in genes involved in the transport, activation, and inactivation of pemetrexed with the outcome of patients with advanced non-small cell lung cancer (NSCLC) treated with pemetrexed. Data from a phase II NSCLC trial evaluating the optimal schedule of gemcitabine and pemetrexed were used. All patients with available DNA were genotyped for polymorphisms in FPGS, GGH, and SLC19A1 genes. Patients with various genotypes were compared for efficacy and adverse events resulting from pemetrexed. Fifty-four patients had genotype results for all polymorphisms studied. Patients with the homozygous variant genotypes for SLC19A1 IVS4(2117) C>T, IVS5(9148) C>A, and wild-type genotype for exon6(2522) C>T had a significantly better overall survival compared with their counterparts (median overall survival in months: 8.9 [CC] versus 14.0 [CT] versus 16.7 [TT]; 9.4 [CC] versus 10.3 [CA] versus 22.7 [AA]; and 22.7 [CC] versus 10.3 [CT] versus 9.4 [TT] respectively; all log rank p = 0.03). Patients with the heterozygous TC genotype for GGH IVS5(1042) T>C had greater rates of confirmed response + stable disease compared with the TT genotype (85% versus 60%; odds ratio = 4.0; p = 0.06). A greater risk for grade 3/4 SGPT (ALT...Continue Reading
References
Apr 3, 1999·The Journal of Biological Chemistry·S C WongL H Matherly
Sep 1, 1999·Proceedings of the National Academy of Sciences of the United States of America·K TangH Köster
Nov 2, 2002·Blood·Caroline LaverdièreMaja Krajinovic
Dec 21, 2002·International Journal of Cancer. Journal International Du Cancer·Esti LianiYehuda G Assaraf
Jul 10, 2003·International Journal of Clinical Oncology·Kenji Omura
Jun 26, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Alex A Adjei
Sep 28, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Yanhua WangI David Goldman
Jun 22, 2005·The Oncologist·Martin H CohenRichard Pazdur
Sep 2, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Cynthia X MaUNKNOWN Eli Lilly & Company
Jul 25, 2006·Clinica Chimica Acta; International Journal of Clinical Chemistry·Erasmus Schneider, Thomas J Ryan
Mar 22, 2007·The Pharmacogenomics Journal·G LiuD C Christiani
May 19, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jean-François CôtéMarc Ychou
Sep 19, 2007·Cancer Research·Tarek A LeilAlex A Adjei
Mar 4, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Charles M RudinMark J Ratain
Jan 24, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michelle A T HildebrandtXifeng Wu
Mar 25, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Egbert F SmitHarry J M Groen
Mar 25, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Helen K ChewKathy S Albain
Citations
Jul 31, 2012·Pharmacogenomics·Elisa GiovannettiGodefridus J Peters
Apr 16, 2014·The Pharmacogenomics Journal·A CorriganA M Marinaki
Jan 17, 2012·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Dal Yong KimJung Shin Lee
Jan 14, 2016·Expert Opinion on Drug Metabolism & Toxicology·Mariacarmela SantarpiaElisa Giovannetti
Jan 15, 2014·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Grace K DyNithya Ramnath
Aug 27, 2014·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Grace K DyAlex A Adjei
Mar 22, 2012·Cancer·Yingwei QiSumithra J Mandrekar
Aug 6, 2013·Investigational New Drugs·Carlos Alvarez-FernandezEmilio Esteban-Gonzalez
Aug 15, 2012·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Marcello TiseoAndrea Ardizzoni
Jun 9, 2016·Pharmacogenomics·Zoulikha M Zaïr, Donald Rj Singer
Jul 7, 2016·Pharmacogenomics·Zoulikha M Zaïr, Donald Rj Singer
Aug 9, 2016·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Cristina Pérez-RamírezMiguel Ÿngel Calleja-Hernández
Apr 18, 2018·The Pharmacogenomics Journal·Cristina Pérez-RamírezMiguel Ángel Calleja-Hernández
Oct 12, 2011·Investigational New Drugs·George R Blumenschein
Sep 5, 2019·Cancer Chemotherapy and Pharmacology·Inthuorn KulmaKesara Na-Bangchang
Apr 20, 2013·Oncology Letters·Wen-Juan LiQiu-Yun Zhang
Dec 19, 2013·Oncology Letters·Min YangJun Wang
Sep 12, 2019·Frontiers in Pharmacology·Xiaoqing ZhangShengying Qin
Oct 3, 2019·Molecular Cancer Therapeutics·Usha MalhotraNikhil Khushalani
Feb 21, 2021·Archives of Pharmacal Research·Hye-Young Min, Ho-Young Lee